Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging

Biomaterials

Volumn 30, Issue 15, 2009, Pages 2919-2928

  Lu, Jian ^a   Ma, Shuli ^a   Sun, Jiayu ^b   Xia, Chunchao ^b   Liu, Chen ^a   Wang, Zhiyong ^a   Zhao, Xuna ^c   Gao, Fabao ^b   Gong, Qiyong ^b   Song, Bin ^b   Shuai, Xintao ^d   Ai, Hua ^a,b   Gu, Zhongwei ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c PHILIPS HEALTHCARE   (United States)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

Block copolymer; Contrast agent; Manganese ferrite; Mouse liver; MRI

Indexed keywords

CONTRAST AGENT; CRYSTALLIZATION TEMPERATURES; DIFFERENTIAL DIAGNOSIS; EFFECTIVE CONTRAST AGENTS; FOURIER TRANSFORM INFRA-RED SPECTROSCOPIES; INTRAVENOUS ADMINISTRATIONS; IRON OXIDE NANOPARTICLES; LIVER CIRRHOSIS; LIVER DISEASE; LIVER IMAGES; LIVER IMAGING; MANGANESE FERRITE; MANGANESE FERRITE NANOPARTICLES; MEAN DIAMETERS; MOLECULAR LEVELS; MOUSE LIVER; MRI; MRI CONTRAST AGENTS; ORGANIC PHASE; RELAXIVITY; ROOM TEMPERATURES; SELF-ASSEMBLED; SIGNAL INTENSITIES; SMALL CLUSTERS; SUPERPARAMAGNETIC; SUPERPARAMAGNETIC IRON OXIDES; TIME WINDOWS; ULTRASENSITIVE;

AGENTS; BLOCK COPOLYMERS; COPOLYMERIZATION; DIAGNOSIS; DIFFERENTIAL SCANNING CALORIMETRY; FERRITE; FERRITES; FOURIER TRANSFORM INFRARED SPECTROSCOPY; FOURIER TRANSFORMS; IRON OXIDES; LIVER; MAGNETIC FIELDS; MAGNETIC RESONANCE IMAGING; MANGANESE COMPOUNDS; MANGANESE REMOVAL (WATER TREATMENT); MEDICAL IMAGING; MICELLES; MOTION PICTURE EXPERTS GROUP STANDARDS; NANOCOMPOSITES; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYMERS; SPECTROSCOPIC ANALYSIS; SUPERPARAMAGNETISM; TRANSMISSION ELECTRON MICROSCOPY;

MANGANESE;

CONTRAST MEDIUM; COPOLYMER; IRON OXIDE; MACROGOL; MANGANESE; MANGANESE FERRITE NANOPARTICLE; NANOCOMPOSITE; NANOPARTICLE; POLY(ETHYLENE GLYCOL) B POLY(EPSILON CAPROLACTONE); SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTRAST ENHANCEMENT; CRYSTALLIZATION; DIFFERENTIAL DIAGNOSIS; DIFFERENTIAL SCANNING CALORIMETRY; HEPATOGRAPHY; HYDROPHOBICITY; INFRARED SPECTROSCOPY; LIVER CIRRHOSIS; LIVER DISEASE; MAGNETIC FIELD; MICELLIZATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CELL LINE, TUMOR; CONTRAST MEDIA; FERRIC COMPOUNDS; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; MANGANESE; METAL NANOPARTICLES; MICE; MICELLES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 62149088943     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.02.001     Document Type: Article

References (52)

1. Schroeder T. Imaging stem-cell-driven regeneration in mammals. Nature 453 7193 (2008) 345-351
2. Herschman H.R. Molecular imaging: looking at problems, seeing solutions. Science 302 5645 (2003) 605-608
3. Bulte J.W., and Kraitchman D.L. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17 7 (2004) 484-499
4. Weissleder R., and Mahmood U. Molecular imaging. Radiology 219 2 (2001) 316-333
5. Wilhelm C., and Gazeau F. Universal cell labeling with anionic magnetic nanoparticles. Biomaterials 29 22 (2008) 3161-3174
6. Wang Y.X., Hussain S.M., and Krestin G.P. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 11 11 (2001) 2319-2331
7. Thorek D.L., Chen A.K., Czupryna J., and Tsourkas A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 34 1 (2006) 23-38
8. Chertok B., Moffat B.A., David A.E., Yu F., Bergemann C., Ross B.D., et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 29 4 (2008) 487-496
9. Jain T.K., Richey J., Strand M., Leslie-Pelecky D.L., Flask C.A., and Labhasetwar V. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials 29 29 (2008) 4012-4021
10. 2 magnetic relaxation switch. Biomaterials 29 6 (2008) 724-732
11. Thorek D.L., and Tsourkas A. Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials 29 26 (2008) 3583-3590
12. Nasongkla N., Bey E., Ren J., Ai H., Khemtong C., Guthi J.S., et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett 6 11 (2006) 2427-2430
13. Bulte J.W., Douglas T., Witwer B., Zhang S.C., Strable E., Lewis B.K., et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 19 12 (2001) 1141-1147
14. de Vries I.J., Lesterhuis W.J., Barentsz J.O., Verdijk P., van Krieken J.H., Boerman O.C., et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 23 11 (2005) 1407-1413
15. Sun S., Murray C.B., Weller D., Folks L., and Moser A. Monodisperse FePt nanoparticles and ferromagnetic FePt nanocrystal superlattices. Science 287 5460 (2000) 1989-1992
16. 4 spinel ferrite nanoparticles. J Am Chem Soc 125 32 (2003) 9828-9833
17. 4 nanoparticles. J Am Chem Soc 126 37 (2004) 11458-11459
18. Tromsdorf U.I., Bigall N.C., Kaul M.G., Bruns O.T., Nikolic M.S., Mollwitz B., et al. Size and surface effects on the MRI relaxivity of manganese ferrite nanoparticle contrast agents. Nano Lett 7 8 (2007) 2422-2427
19. Lee J.H., Huh Y.M., Jun Y., Seo J., Jang J., Song H.T., et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 13 1 (2007) 95-99
20. 4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc 126 1 (2004) 273-279
21. Lu A.H., Salabas E.L., and Schuth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed Engl 46 8 (2007) 1222-1244
22. Kwon G.S., and Okano T. Polymeric micelles as new drug carriers. Adv Drug Deliv Rev 21 2 (1996) 107-116
23. Kakizawa Y., and Kataoka K. Block copolymer micelles for delivery of gene and related compounds. Adv Drug Deliv Rev 54 2 (2002) 203-222
24. Croy S.R., and Kwon G.S. Polymeric micelles for drug delivery. Curr Pharm Des 12 36 (2006) 4669-4684
25. Shuai X., Ai H., Nasongkla N., Kim S., and Gao J. Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J Control Release 98 3 (2004) 415-426
26. Nasongkla N., Shuai X., Ai H., Weinberg B.D., Pink J., Boothman D.A., et al. cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew Chem Int Ed Engl 43 46 (2004) 6323-6327
27. Kim T.Y., Kim D.W., Chung J.Y., Shin S.G., Kim S.C., Heo D.S., et al. Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin Cancer Res 10 11 (2004) 3708-3716
28. Matsumura Y., Hamaguchi T., Ura T., Muro K., Yamada Y., Shimada Y., et al. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer 91 10 (2004) 1775-1781
29. Ai H., Flask C., Weinberg B., Shuai X., Pagel M.D., Farrell D., et al. Magnetite-loaded polymeric micelles as ultrasensitive magnetic-resonance probes. Adv Mater 17 16 (2005) 1949-1952
30. Wang Z.Y., Liu G., Sun J.Y., Wu B., Gong Q.Y., Song B., et al. Self-assembly of magnetite nanocrystals with amphiphilic polyethylenimine: structures and applications in magnetic resonance imaging. J Nanosci Nanotechnol 9 1 (2009) 378-385
31. Dubertret B., Skourides P., Norris D.J., Noireaux V., Brivanlou A.H., and Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 298 5599 (2002) 1759-1762
32. Gao X., Cui Y., Levenson R.M., Chung L.W., and Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22 8 (2004) 969-976
33. Zhou S.B., Deng X.M., and Yang H. Biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system. Biomaterials 24 20 (2003) 3563-3570
34. Kim S.Y., Lee Y.M., Baik D.J., and Kang J.S. Toxic characteristics of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) nanospheres; in vitro and in vivo studies in the normal mice. Biomaterials 24 1 (2003) 55-63
35. Park E.K., Lee S.B., and Lee Y.M. Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials 26 9 (2005) 1053-1061
36. Kim S.Y., Shin I.G., and Lee Y.M. Amphiphilic diblock copolymeric nanospheres composed of methoxy poly(ethylene glycol) and glycolide: properties, cytotoxicity and drug release behaviour. Biomaterials 20 11 (1999) 1033-1042
37. Wilson D.L., Kump K.S., Eppell S.J., and Marchant R.E. Morphological restoration of atomic force microscopy images. Langmuir 11 (1995) 265
38. Xie J., Peng S., Brower N., Pourmand N., Wang S.X., and Sun S. One-pot synthesis of monodisperse iron oxide nanoparticles for potential biomedical applications. Pure Appl Chem 78 (2006) 1003-1014
39. Josephson L., Lewis J., Jacobs P., Hahn P.F., and Stark D.D. The effects of iron oxides on proton relaxivity. Magn Reson Imaging 6 6 (1988) 647-653
40. Ditsch A., Laibinis P.E., Wang D.I.C., and Hatton A.T. Controlled clustering and enhanced stability of polymer-coated magnetic nanoparticles. Langmuir 21 (2005) 6006-6018
41. Berret J.F., Schonbeck N., Gazeau F., El Kharrat D., Sandre O., Vacher A., et al. Controlled clustering of superparamagnetic nanoparticles using block copolymers: design of new contrast agents for magnetic resonance imaging. J Am Chem Soc 128 5 (2006) 1755-1761
42. 2 NMRD profiles of solutions of magnetic nanoparticles. Magn Reson Med 34 2 (1995) 227-233
43. Shuai X.T., Porbeni F.E., Wei M., Bullions T., and Tonelli A.E. Formation of inclusion complexes of poly(3-hydroxybutyrate)s with cyclodextrins. 1. Immobilization of atactic poly(R,S-3-hydroxybutyrate) and miscibility enhancement between poly(R,S-3-hydroxybutyrate) and poly(epsilon-caprolactone). Macromolecules 35 8 (2002) 3126-3132
44. Aguirre D.A., Behling C.A., Alpert E., Hassanein T.I., and Sirlin C.B. Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology 239 2 (2006) 425-437
45. Kato N., Ihara S., Tsujimoto T., and Miyazawa T. Effect of resovist on rats with different severities of liver cirrhosis. Invest Radiol 37 5 (2002) 292-298
46. Reimer P., and Balzer T. Ferucarbotran (resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 13 6 (2003) 1266-1276
47. Kim S.H., Choi D., Lim H.K., Kim M.J., Jang K.M., Kim S.H., et al. Detection of hepatic VX2 carcinomas with ferucarbotran-enhanced magnetic resonance imaging in rabbits: comparison of nine pulse sequences. Eur J Radiol 59 3 (2006) 413-423
48. 2-weighted MRI of the liver. Acad Radiol 9 Suppl. 2 (2002) S336-S338
49. Weissleder R., Hahn P.F., Stark D.D., Elizondo G., Saini S., Todd L.E., et al. Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging. Radiology 169 2 (1988) 399-403
50. Shamsi K., Balzer T., Saini S., Ros P.R., Nelson R.C., Carter E.C., et al. Superparamagnetic iron oxide particles (SHU 555 A): evaluation of efficacy in three doses for hepatic MR imaging. Radiology 206 2 (1998) 365-371
51. Pouliquen D., Le Jeune J.J., Perdrisot R., Ermias A., and Jallet P. Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism. Magn Reson Imaging 9 3 (1991) 275-283
52. Moghimi S.M., Hunter A.C., and Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53 2 (2001) 283-318